NASDAQ: PDEXPro Dex Inc Stock Ownership - Who owns Pro Dex?
Insider buying vs selling
Have Pro Dex Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Angelita Rebamontan Domingo | Director | 2026-01-22 | 18 | $34.36 | $618.48Buy |
| Katrina Marie Kramer Philp | Director | 2025-11-21 | 2,200 | $32.70 | $71.94kBuy |
| Katrina Marie Kramer Philp | Director | 2025-11-21 | 900 | $32.73 | $29.46kBuy |
| Alisha Charlton | Chief Financial Officer | 2025-11-20 | 72 | $30.83 | $2.22kSell |
| Kirk Richard Lee Van Jr. | Chief Executive Officer | 2025-11-20 | 72 | $30.83 | $2.22kSell |
| Angelita Rebamontan Domingo | Director | 2025-11-20 | 72 | $30.83 | $2.22kSell |
| Angelita Rebamontan Domingo | Director | 2025-07-24 | 15 | $42.34 | $635.10Buy |
| Raymond E. Cabillot | Director | 2025-04-01 | 7,263 | $50.01 | $363.22kSell |
| Raymond E. Cabillot | Director | 2025-03-31 | 836 | $50.00 | $41.80kSell |
| Raymond E. Cabillot | Director | 2025-03-28 | 842 | $50.00 | $42.10kSell |
PDEX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when PDEX insiders and whales buy or sell their stock.
PDEX Shareholders
What type of owners hold Pro Dex Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Nicholas John Swenson | 108.43% | 3,476,295 | $136.38M | Insider |
| Ronald G. Coss | 100.96% | 3,236,637 | $126.97M | Insider |
| Raymond E. Cabillot | 19.77% | 633,692 | $24.86M | Insider |
| Mark Phillip Murphy | 19.37% | 621,131 | $24.37M | Insider |
| Patrick L. Johnson | 13.52% | 433,430 | $17.00M | Insider |
| Peter O. Haeg | 11.35% | 363,846 | $14.27M | Insider |
| Blackrock Inc | 4.86% | 155,876 | $6.12M | Institution |
| George J. Isaac | 4.66% | 149,500 | $5.86M | Insider |
| Vanguard Group Inc | 4.56% | 146,137 | $5.73M | Institution |
| Jeffrey J. Ritchey | 4.24% | 136,000 | $5.34M | Insider |
PDEX vs Medical Stocks
Pro Dex Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.